What is MaxCyte's enterprise value?

MaxCyte (MXCT) reported enterprise value of $78M in Q1 2026.

How has MaxCyte's enterprise value changed year-over-year?

MaxCyte's enterprise value decreased by 72.6% year-over-year, from $284.89M to $78M.

What is the long-term trend for MaxCyte's enterprise value?

Over 4 years (2021 to 2025), MaxCyte's enterprise value has grown at a -36.3% compound annual growth rate (CAGR), from $990.21M to $163.22M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

MaxCyte MXCT Enterprise value

Enterprise value at other companies

Bio-Rad LaboratoriesBIO

$8B+4.2%

Thermo Fisher ScientificTMO

$222.48B+0.9%

Ginkgo BioworksDNA

$601.63M+46.8%

Immix Biopharma, Inc.IMMX

$404.29M+1,175%

Rapid Micro BiosystemsRPID

$112.87M+12.0%

PDE

Pro-Dex, Inc.PDEX

$163.47M-2.9%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Calculated from MaxCyte’s reported figures.

$75.1Mmarket cap+$17.5Mtotal debt−$14.6Mcash and equivalents=$78M

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's enterprise value?: MaxCyte (MXCT) reported enterprise value of $78M in Q1 2026.
How has MaxCyte's enterprise value changed year-over-year?: MaxCyte's enterprise value decreased by 72.6% year-over-year, from $284.89M to $78M.
What is the long-term trend for MaxCyte's enterprise value?: Over 4 years (2021 to 2025), MaxCyte's enterprise value has grown at a -36.3% compound annual growth rate (CAGR), from $990.21M to $163.22M.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.